The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Cetin, B.Tastekin, D.Aktas, B.Guler, T.Kaplan, M. A.Berk, V.Gumusay, O.2024-04-242024-04-2420130959-80491879-0852https://hdl.handle.net/11468/23074European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survivalThe effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survivalConference Object49S632S632WOS:000326843604074Q1